» Articles » PMID: 21474764

Differential Genome-wide Profiling of Tandem 3' UTRs Among Human Breast Cancer and Normal Cells by High-throughput Sequencing

Overview
Journal Genome Res
Specialty Genetics
Date 2011 Apr 9
PMID 21474764
Citations 167
Authors
Affiliations
Soon will be listed here.
Abstract

Tandem 3' UTRs produced by alternative polyadenylation (APA) play an important role in gene expression by impacting mRNA stability, translation, and translocation in cells. Several studies have investigated APA site switching in various physiological states; nevertheless, they only focused on either the genes with two known APA sites or several candidate genes. Here, we developed a strategy to study APA sites in a genome-wide fashion with second-generation sequencing technology which could not only identify new polyadenylation sites but also analyze the APA site switching of all genes, especially those with more than two APA sites. We used this strategy to explore the profiling of APA sites in two human breast cancer cell lines, MCF7 and MB231, and one cultured mammary epithelial cell line, MCF10A. More than half of the identified polyadenylation sites are not included in human poly(A) databases. While MCF7 showed shortening 3' UTRs, more genes in MB231 switched to distal poly(A) sites. Several gene ontology (GO) terms and pathways were enriched in the list of genes with switched APA sites, including cell cycle, apoptosis, and metabolism. These results suggest a more complex regulation of APA sites in cancer cells than previously thought. In short, our novel unbiased method can be a powerful approach to cost-effectively investigate the complex mechanism of 3' UTR switching in a genome-wide fashion among various physiological processes and diseases.

Citing Articles

CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells.

Tietz K, McCluskey B, Miller C, Li Y, Munro S, Dehm S Cell Rep. 2025; 44(1):115211.

PMID: 39847481 PMC: 11831233. DOI: 10.1016/j.celrep.2024.115211.


Coupling of alternative splicing and alternative polyadenylation.

Zhang X, Liu F, Zhou Y Acta Biochim Biophys Sin (Shanghai). 2024; 57(1):22-32.

PMID: 39632657 PMC: 11802343. DOI: 10.3724/abbs.2024211.


The role of alternative polyadenylation in breast cancer.

Qiao P, Zhang C, Shi Y, Du H Front Genet. 2024; 15:1377275.

PMID: 38939531 PMC: 11208690. DOI: 10.3389/fgene.2024.1377275.


Disruption of PABPN1 phase separation by SNRPD2 drives colorectal cancer cell proliferation and migration through promoting alternative polyadenylation of CTNNBIP1.

Hu Z, Li M, Chen Y, Chen L, Han Y, Chen C Sci China Life Sci. 2024; 67(6):1212-1225.

PMID: 38811444 DOI: 10.1007/s11427-023-2495-x.


Downregulation of CPSF6 leads to global mRNA 3' UTR shortening and enhanced antiviral immune responses.

Ge Y, Huang J, Chen R, Fu Y, Ling T, Ou X PLoS Pathog. 2024; 20(2):e1012061.

PMID: 38416782 PMC: 10927093. DOI: 10.1371/journal.ppat.1012061.


References
1.
Pickrell J, Marioni J, Pai A, Degner J, Engelhardt B, Nkadori E . Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature. 2010; 464(7289):768-72. PMC: 3089435. DOI: 10.1038/nature08872. View

2.
Ramljak D, Romanczyk L, Metheny-Barlow L, Thompson N, Knezevic V, Galperin M . Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells. Mol Cancer Ther. 2005; 4(4):537-46. DOI: 10.1158/1535-7163.MCT-04-0286. View

3.
Beaudoing E, Freier S, Wyatt J, Claverie J, Gautheret D . Patterns of variant polyadenylation signal usage in human genes. Genome Res. 2000; 10(7):1001-10. PMC: 310884. DOI: 10.1101/gr.10.7.1001. View

4.
Bertone P, Stolc V, Royce T, Rozowsky J, Urban A, Zhu X . Global identification of human transcribed sequences with genome tiling arrays. Science. 2004; 306(5705):2242-6. DOI: 10.1126/science.1103388. View

5.
Aptsiauri N, Cabrera T, Mendez R, Garcia-Lora A, Ruiz-Cabello F, Garrido F . Role of altered expression of HLA class I molecules in cancer progression. Adv Exp Med Biol. 2007; 601:123-31. DOI: 10.1007/978-0-387-72005-0_13. View